GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yantai Dongcheng Biochemicals Co Ltd (SZSE:002675) » Definitions » Piotroski F-Score

Yantai Dongcheng Biochemicals Co (SZSE:002675) Piotroski F-Score : 6 (As of Dec. 12, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Yantai Dongcheng Biochemicals Co Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Yantai Dongcheng Biochemicals Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Yantai Dongcheng Biochemicals Co's Piotroski F-Score or its related term are showing as below:

SZSE:002675' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 5   Max: 7
Current: 6

During the past 13 years, the highest Piotroski F-Score of Yantai Dongcheng Biochemicals Co was 7. The lowest was 3. And the median was 5.


Yantai Dongcheng Biochemicals Co Piotroski F-Score Historical Data

The historical data trend for Yantai Dongcheng Biochemicals Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yantai Dongcheng Biochemicals Co Piotroski F-Score Chart

Yantai Dongcheng Biochemicals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 6.00 4.00 6.00 4.00

Yantai Dongcheng Biochemicals Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 4.00 3.00 5.00 6.00

Competitive Comparison of Yantai Dongcheng Biochemicals Co's Piotroski F-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Yantai Dongcheng Biochemicals Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yantai Dongcheng Biochemicals Co's Piotroski F-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yantai Dongcheng Biochemicals Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Yantai Dongcheng Biochemicals Co's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Net Income was -76.076 + 64.328 + 47.462 + 55.078 = ¥91 Mil.
Cash Flow from Operations was 177.125 + -165.319 + 147.532 + 202.733 = ¥362 Mil.
Revenue was 690.304 + 647.229 + 773.482 + 741.721 = ¥2,853 Mil.
Gross Profit was 337.049 + 283.448 + 350.794 + 350.643 = ¥1,322 Mil.
Average Total Assets from the begining of this year (Sep23)
to the end of this year (Sep24) was
(8288.822 + 8082.354 + 8529.18 + 8668.887 + 8643.91) / 5 = ¥8442.6306 Mil.
Total Assets at the begining of this year (Sep23) was ¥8,289 Mil.
Long-Term Debt & Capital Lease Obligation was ¥314 Mil.
Total Current Assets was ¥2,633 Mil.
Total Current Liabilities was ¥1,663 Mil.
Net Income was -23.019 + 50.107 + 134.2 + 101.505 = ¥263 Mil.

Revenue was 841.514 + 850.5 + 934.51 + 800.333 = ¥3,427 Mil.
Gross Profit was 383.486 + 403.494 + 392.565 + 336.582 = ¥1,516 Mil.
Average Total Assets from the begining of last year (Sep22)
to the end of last year (Sep23) was
(8502.556 + 8176.965 + 8264.585 + 8380.958 + 8288.822) / 5 = ¥8322.7772 Mil.
Total Assets at the begining of last year (Sep22) was ¥8,503 Mil.
Long-Term Debt & Capital Lease Obligation was ¥289 Mil.
Total Current Assets was ¥2,856 Mil.
Total Current Liabilities was ¥2,117 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Yantai Dongcheng Biochemicals Co's current Net Income (TTM) was 91. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Yantai Dongcheng Biochemicals Co's current Cash Flow from Operations (TTM) was 362. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep23)
=90.792/8288.822
=0.01095355

ROA (Last Year)=Net Income/Total Assets (Sep22)
=262.793/8502.556
=0.03090753

Yantai Dongcheng Biochemicals Co's return on assets of this year was 0.01095355. Yantai Dongcheng Biochemicals Co's return on assets of last year was 0.03090753. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Yantai Dongcheng Biochemicals Co's current Net Income (TTM) was 91. Yantai Dongcheng Biochemicals Co's current Cash Flow from Operations (TTM) was 362. ==> 362 > 91 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep23 to Sep24
=313.558/8442.6306
=0.03713985

Gearing (Last Year: Sep23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep22 to Sep23
=288.766/8322.7772
=0.03469587

Yantai Dongcheng Biochemicals Co's gearing of this year was 0.03713985. Yantai Dongcheng Biochemicals Co's gearing of last year was 0.03469587. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep24)=Total Current Assets/Total Current Liabilities
=2633.125/1662.584
=1.58375457

Current Ratio (Last Year: Sep23)=Total Current Assets/Total Current Liabilities
=2856.24/2117.052
=1.34915911

Yantai Dongcheng Biochemicals Co's current ratio of this year was 1.58375457. Yantai Dongcheng Biochemicals Co's current ratio of last year was 1.34915911. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Yantai Dongcheng Biochemicals Co's number of shares in issue this year was 824.524. Yantai Dongcheng Biochemicals Co's number of shares in issue last year was 824.57. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1321.934/2852.736
=0.46339164

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1516.127/3426.857
=0.44242494

Yantai Dongcheng Biochemicals Co's gross margin of this year was 0.46339164. Yantai Dongcheng Biochemicals Co's gross margin of last year was 0.44242494. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep23)
=2852.736/8288.822
=0.34416664

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep22)
=3426.857/8502.556
=0.40303845

Yantai Dongcheng Biochemicals Co's asset turnover of this year was 0.34416664. Yantai Dongcheng Biochemicals Co's asset turnover of last year was 0.40303845. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+0+1+1+1+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Yantai Dongcheng Biochemicals Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Yantai Dongcheng Biochemicals Co  (SZSE:002675) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Yantai Dongcheng Biochemicals Co Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Yantai Dongcheng Biochemicals Co's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Yantai Dongcheng Biochemicals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 7 ChangBaishan Road, Yan Tai Development Zone, ShanDong, CHN, 264006
Yantai Dongcheng Biochemicals Co Ltd is a biochemical analytical profile index (API) manufacturers in China. In addition, the company also focuses on the development of finished preparation which covers the therapeutic area of cardiovascular, oncology, orthopedics, and anti-infection. Its product offering includes heparin sodium, chondroitin sulfate, marine collagen, hyaluronic acid, glucosamine, heparinoids, and cytochrome C. The company's API products have been exported to more than fifty countries and regions, including the United States of America, Germany, Austria, and Japan.
Executives
Xin Hong Bo Directors, executives
Luo Zhi Gang Executives
You Shou Yi Directors, executives
Lv Chun Xiang Supervisors
Sun Hong Tao Supervisors
Yi Qiong Executives
Yang Zhen Qiu Executives
Bai Xing Hua Directors, executives
Song Zhao Long Supervisors
Wen Lei Director
Zhu Chun Ping Executives
Qi Dong Qi Directors, executives
Liu Xiao Jie Securities Affairs Representative
Wang En Zheng Independent director
Shi Tao Supervisors

Yantai Dongcheng Biochemicals Co Headlines

No Headlines